9 November 2023 in S.S. Korsakov Journal of Neurology and Psychiatry
Guillain—Barré syndrome (GBS) is an immune-mediated disease of the peripheral nervous system that can occur in both children and adults. The classic presentation of GBS is characterized by progressive symmetrical, ascending muscle weakness. Patients with GBS require meticulous monitoring due to the risk of bulbar syndrome, respiratory failure and autonomic dysfunction, which can be life-threatening. Early diagnosis and timely prescription of pathogenetic therapy for GBS are particularly important, especially in young children. Meanwhile, the spectrum of disorders covered by GBS has expanded significantly; its eponym is now designate any variant of acute dysimmune polyneuropathy, and its atypical forms pose a serious diagnostic problem for clinicians. This review article provides an analysis of the data available in the medical literature on GBS in children and discusses the tactics for diagnosing and managing patients with GBS, taking into account the Russian and European clinical recommendations.
30 April 2018 in Neuromuscular Diseases
The DNA analysis revealed a transthyretin amyloidosis with a rare Phe53Leu mutation in a woman of 62 y.o. with the late onset progressive generalized axonal sensomotor neuropathy, dry eye syndrome, and an episode of severe unintentionally weight loss. The same mutation was found in her healthy 34 y.o. son, but not in a 42 y.o. daughter. The Congo red staining were negative in nerve and salivar gland biopsies samples. The reassessment of the transthyretin amyloidosis “red flags” showed that the patient fulfilled the criteria of the disease and the absence of amyloid deposition was not the ground to reject the hereditary cause of the condition. The reasons of the misdiagnosis are discussed.
3 April 2023 in Burdenko's Journal of Neurosurgery
Background. The authors present severe compression of the median nerve by iatrogenic false aneurysm of the brachial artery combined with carpal tunnel syndrome. Material and methods. An 81-year-old woman developed acute anesthesia of fingers I-III of the left hand, impaired flexion of the thumb and forefinger, swelling of the hand and forearm, local pain in postoperative period after angiography. The patient was previously followed-up for transient numbness in both hands for 2 years with a diagnosis of carpal tunnel syndrome. Electroneuromyography and ultrasound of the median nerve at the level of shoulder and forearm were carried out. We visualized a pulsatile lesion with Tinel’s sign within the elbow (false aneurysm of the brachial artery). Results. Resection of brachial artery aneurysm and neurolysis of the left median nerve were followed by regression of pain syndrome and improvement of motor function of the hand. Conclusion. This case demonstrates a rare variant of acute high compression of the median nerve after diagnostic angiography. This situation should be considered in differential diagnosis with classical carpal tunnel syndrome.
24 April 2019 in Neuromuscular Diseases
Today the description of phenomenon of the focal “hourglass-like constriction” of the peripheral nerves in patients with acute pain mononeuropathy is often found in literature. The use of additional imaging techniques of peripheral nerves such as high-resolution ultrasound and magnetic resonance imaging allowed to detect this pathology more often. The purpose of the review is to summarize information about the phenomenon of the focal “hourglass-like constriction”. We analyzed 30 publications in PubMed database by key words: “Hourglass like construction of peripheral nerve” with the description of 158 patients with the focal “hourglass-like constriction”.
30 March 2026 in Annals of Clinical and Experimental Neurology
Introduction. Chemotherapy (CT) with platinum and taxane drugs often leads to chemotherapy-induced peripheral neuropathy (CIPN), which significantly impairs patients’ quality of life. CIPN is diagnosed based on symptoms and neurological examination, which underscores the need for objective biomarkers. Promising criteria for peripheral nerve damage are neurofilaments, in particular the light chain (NfL) and peripherin. NfL is released during axonal damage but is not specific to the peripheral nervous system. Peripherin, in contrast, is expressed exclusively in peripheral neurons and is considered a more specific marker; however, its detection is challenging. The aim of the study was to evaluate serum levels of neurofilament and peripherin using the ELISA method in patients with solid tumors undergoing CT. Materials and methods. The study included 66 patients with newly diagnosed solid tumors before starting CT with platinum or taxanes. Patients with known risk factors for polyneuropathy and those taking medications with neurotoxic effects were excluded. After treatment, 51 patients were examined. Neurological examination with assessment using the NCI-CTCAE and NDS scales, nerve conduction study (SRAR index, amplitude of the sural nerve action potential), and assessment of intraepidermal nerve fiber density were performed. Serum levels of NfL and peripherin were measured using ELISA before and approximately 4.5 months after CT. Preanalytical sample processing was standardized. Results. After the CT course all patients showed a significant increase in NfL levels (p 0.0003). The most pronounced increase in the indicator (~fivefold) was recorded in male patients (p 0.001) and in the group of patients with malignant neoplasms in the gastrointestinal tract (p = 0.001). The concentration of peripherin in all analyzed samples was zero, likely due to the low ELISA sensitivity. In patients with developed CIPN, the NfL level after treatment was significantly higher (p = 0.001); however, no prognostic value for predicting neuropathy was found (AUC = 0.526; p = 0.803). At the same time, a moderate negative correlation was found between the NfL level and the density of intraepidermal nerve fibers (r = –0.416; p = 0.012). No statistically significant association was found between NfL concentration and electrophysiological parameters (SRAR index and sural nerve action potential amplitude). Conclusion. NfL is a promising but insufficiently specific biomarker for monitoring patients with CIPN. The absence of a detectable level of peripherin by ELISA limits its clinical application and suggests the use of more sensitive analytical methods.
26 June 2025 in Annals of Clinical and Experimental Neurology
Introduction. Electrophysiological testing is the gold standard for diagnosing polyneuropathy. However, its use in oncology practice for patients with chemotherapy-induced polyneuropathy (CIPN) remains limited and the value of its findings is not fully understood. The study was aimed at identifying electrophysiological CIPN markers and evaluting their sensitivity and specificity. Materials and methods. The study included patients (n = 71) over 18 years of age with solid tumor presenting with polyneuritic complaints following neurotoxic therapy with platinum-based agents and taxanes. Patients with known risk factors for polyneuropathy were excluded. Electrophysiological and clinical patient data were evaluated no earlier than 3 months following chemotherapy initiation. Results. The study identified electromyographic markers: SRAR index (sural/radial ratio — the ratio between the action potential amplitudes of the sural and radial nerves) and the sural nerve action potential (SNAP), demonstrating equal sensitivity (73.7%) and high specificity (75% and 84.6%, respectively). Conclusion. Electromyographic parameters such as SRAR and SNAP sural nerve can be utilized for the diagnosis and monitoring of CIPN in daily practice.